NEW YORK (GenomeWeb News) – The UK’s Institute of Cancer Research will use Thermo Fisher Scientific’s proteomics technologies in an integrative network biology initiative, the company said today.

ICR will use Thermo’s TSQ Vantage triple quadrupole system, the Kingfisher Flex sample prep system, two LTQ Orbitrap Velos mass spectrometers, and other technologies, the company said.

The agreement includes lab equipment, protein reagents, mass spectrometry, RNA silencing, and related services.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: multiplex genotyping of germline and somatic short tandem repeats, graph-based regularization, and more.

A lack of funding may lead more than two dozen research facilities in Australia to shut down in three months.

Researchers report that paternally inherited genes are more likely to be expressed in mice.

In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.

Mar
05
Sponsored by
SomaLogic

In this live webcast, Robert Gerszten of Massachusetts General Hospital will describe an ongoing project that is integrating metabolic and proteomic profiling to gain a better understanding of cardiometabolic disease.